跳至主要内容
临床试验/2024-516793-30-00
2024-516793-30-00招募中3 期

Study of post-total thyroidectomy hypocalcemia after preoperative cholecalciferol supplementation.

Hopital NOVO4 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2024年10月16日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
Hopital NOVO
入组人数
200
试验地点
4
主要终点
Measure of the occurrence of serum and / or clinical hypocalcemia Serum hypocalcemia is defined by a level of calcemia, corrected for albuminemia, of less than 2.00 mmol / L. Clinical hypocalcemia is defined by the appearance of one of the following signs: sign of Chvostek, sign of Trousseau, paresthesias of the extremities and perioral between surgery and D15

研究概览

简要总结

Assessment of the effect of pre-operative cholecalciferol supplementation on the occurrence of post-operative hypocalcemia aftertotal thyroidectomy

入排标准

年龄范围
18 years 至 65+ years(65+ Years, 18-64 Years)
接受健康志愿者

入选标准

  • Patient ≥ 18 years old
  • Patient shall be operated on for a total thyroidectomy in one time for any indication
  • Written informed consent (IC) obtained
  • Patients with affiliation to the social security system

排除标准

  • Medical history of : thyroid or parathyroid surgery, Hyperparathyroidism , granulomatosis flare-up
  • Pregnant women
  • Vulnerable populations (guardianship or trusteeship)
  • Persons deprived of their liberty by court or administrative decision
  • Chronic kidney disease grade ≥4
  • 25OHD supplementation within last 3 months before surgery
  • Malabsorption syndrome
  • Known hypersensitivity to vitamin D
  • Allergies to one of the components of the fruit juice
  • Medical history of calcic lithiasis
  • Hypocalcemia, hypercalcemia/ hypercalciuria, or symptom of Hypocalcemia, hypercalcemia/ hypercalciuria, not due to thyroid pathologies
  • Severe liver failure

结局指标

主要结局

Measure of the occurrence of serum and / or clinical hypocalcemia Serum hypocalcemia is defined by a level of calcemia, corrected for albuminemia, of less than 2.00 mmol / L. Clinical hypocalcemia is defined by the appearance of one of the following signs: sign of Chvostek, sign of Trousseau, paresthesias of the extremities and perioral between surgery and D15

Measure of the occurrence of serum and / or clinical hypocalcemia Serum hypocalcemia is defined by a level of calcemia, corrected for albuminemia, of less than 2.00 mmol / L. Clinical hypocalcemia is defined by the appearance of one of the following signs: sign of Chvostek, sign of Trousseau, paresthesias of the extremities and perioral between surgery and D15

次要结局

  • Duration of initial hospitalization (number of hospital days), collect of adverse events and number of readmissions
  • Measure of severity of hypocalcemia defined by a calcemia corrected for albuminemia of less than 1.90 mmol / L and / or the use of calcium gluconate IV in the first 15 post-operative days.
  • Measure of duration of hypocalcemia's symptoms in the first 15 days postoperative
  • Vitamin D deficiency will be measured by comparing the initial value of 25OHD at the inclusion visit to the value of 25OHD of the day of the operation (D0=H0)
  • Collect of the number of adverse events and serum calcium levels for each participant
  • Collect of the definitive hypocalcemia's numbers in each group
  • Parathyroid activity will be evaluated in both group by measuring parathormone (PTH). Hypoparathyroidism being defined by PTH < 15 ng / L.

研究者

发起方
Hopital NOVO
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

AL TABAA Khaled

Scientific

Hopital NOVO

研究点 (4)

Loading locations...

相似试验